1. Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
2. Funding the Working Capital Requirement of our Company
3. To meet out the General Corporate Purposes
...
in Noida, Uttar Pradesh, India. In vitro diagnostics (IVDs) are tests that can detect disease, conditions andinfections. In vitro simply means ‘in glass’, meaning these tests are typically conducted in test tubes and similar equipment, asopposed to in vivo tests, which are conducted in the body itself. In vitro tests can be done in laboratories, health care facilities oreven in the home. The tests themselves can be performed on a variety of instruments ranging from small, handheld tests to complexlaboratory instruments.Avience Biomedicals Limited commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM),Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions withaffordable and good-quality solutions. Avience Biomedicals Limited has expanded its product range from IVD rapid test kits toinclude a comprehensive line of medical devices such as Serology products, Biochemistry Analyser and Biochemistry Reagents,showcasing a dedication to addressing various healthcare needs. Being purely into B2B and B2G market, our products cater toPathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas. In addition to manufacturing,the Company also act as distributors and traders of medical equipments Read MoreSkyline Financial Services Pvt Ltd
Posted on Dec 27th
Modella Woollens informs about closure of trading window
Posted on Dec 26th
Currency futures for December expiry trade tad weaker with 71.49% increase in OI
Posted on Dec 26th
India's goods and services exports may grow by 3% to $850 billion in FY26: GTRI
Posted on Dec 24th
E to E Transportation Infrastructure coming with IPO to raise Rs 84 crore
The issue size of Avience Biomedicals Ltd. IPO is ₹0.00 - 0.00 crore.
The Avience Biomedicals Ltd. IPO opens for subscription on and closes on .
The price range of Avience Biomedicals Ltd. IPO is ₹0.00 to ₹0.00.
The lot size of Avience Biomedicals Ltd. IPO is shares.
The registrar of Avience Biomedicals Ltd. IPO is Skyline Financial Services Pvt Ltd .
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.